Autodesk: Analysts' Upgrades, Downgrades
NEW YORK (
) --
CHANGE IN RATINGS
Apache
(APA) - Get Free Report
downgraded at Goldman from Buy to Neutral. Valuation call, though estimates were boosted because of lower production costs. $128 price target.
Autodesk
(ADSK) - Get Free Report
upgraded at Needham from Hold to Buy. $31 price target. Company is positioned well to benefit from a new up-cycle.
EOG Resources
(EOG) - Get Free Report
upgraded at Goldman from Neutral to Buy. Company trades at an attractive valuation and can deliver 18% production growth in 2011.
FPL Group
(FPL) - Get Free Report
upgraded at Credit Suisse to Outperform from Neutral on valuation and a strong cash position. $56 price target. 2009 and 2010 EPS estimates set at $4.08 and $4.36, respectively.
Homex
undefined
downgraded at Credit Suisse to Underperform from Neutral as competition in the Mexican housing market is picking up.
Iconix Brand
(ICON) - Get Free Report
downgraded at BofA/Merrill to Neutral from Buy on worries that organic growth in 2H10 could be challenging. Price target reduced to $15 from $18.
ONEOK Partners
(OKS)
upgraded at Citi to Buy from Hold on valuation and bullish on OKS's NGL assets. Maintain $65 price target.
STEC
(STEC)
downgraded at Thomas Weisel to Market Weight from Overweight on SSD inventory overhang at its largest customer EMC. Price target plunged to $8 from $31. 2010 EPS estimate lowered to $0.30 from $2.05.
Under Armour
(UA) - Get Free Report
upgraded at Morgan Stanley from Underweight to Equal-weight. Stock is pricing in lower shoe sales and markdown trends are improving. New $27 price target.
STOCK COMMENTS / EPS CHANGES
Autodesk
(ADSK) - Get Free Report
price target increased at BofA/Merrill to $29 from $27 on sustainable growth. 2011 EPS raised to 72 cents, 2012 cut to 94 cents. Neutral rating.
Autodesk
(ADSK) - Get Free Report
estimates, target boosted at UBS. ADSK estimates were increased through 2012. Company is seeing accelerating demand momentum. Buy rating and new $36 price target.
Amedisys
(AMED) - Get Free Report
estimates, target increased at UBS. Shares of AMED now seen reaching $70. Estimates also raised, because of Medicare rate increases. Buy rating.
Blue Coat Systems
(BCSI)
target, estimates boosted at BofA/Merrill. BCSI price target raised by $2 to $32 on better revenues and margins. Estimates improved through 2012. Maintain Buy rating.
Blue Coat Systems
(BCSI)
numbers increased at FBR. Shares of BCSI now seen reaching $28. Estimates also boosted, because of early success of the company's restructuring plan. Market Perform rating.
Barnes & Noble
(BKS) - Get Free Report
numbers reduced at Goldman. BKS estimates were cut through 2012. Company is boosting its digital investments. Sell rating and new $16 price target.
Church & Dwight
(CHD) - Get Free Report
numbers boosted at Goldman. CHD estimates were increased through 2012. Company is seeing higher gross margins. Neutral rating and new $72 price target.
Cleco
(CNL)
numbers reduced at Goldman. CNL estimates were lowered through 2012. JPM agreement will hurt earnings. Sell rating and new $26 price target.
Genworth Financial
(GNW) - Get Free Report
target raised at UBS. GNW target was upped to $18.50. Company is improving its ROE, with the outlook for mortgage insurance improving. Buy rating.
Home Depot
(HD) - Get Free Report
estimates raised at Morgan Stanley through 2011. Company is seeing higher EBIT margins, as housing recovers. Overweight rating and $35 price target.
Home Depot
(HD) - Get Free Report
numbers boosted at Goldman. HD estimates were increased through 2012. Company is realizing higher EBIT margins. Buy rating and new $35 price target.
Health Management
(HMA)
estimates raised at Goldman through 2011. Company is seeing a better environment for bad-debt expenses. Neutral rating and $9 price target.
IPG Photonics
(IPGP) - Get Free Report
target, estimates cut at BofA/Merrill. IPGP price target trimmed by a dollar to $20. 4Q09 results top line beat, but margins lag noted Bank of America/Merrill Lynch. 2010 EPS estimate lowered to 46 cents. Maintain Buy rating.
Kimberly-Clark
(KMB) - Get Free Report
numbers cut at Goldman. Shares of KMB now seen reaching $63. Estimates also lowered, because of expected commodity inflation. Neutral rating.
Lowe's
(LOW) - Get Free Report
estimates upped at Morgan Stanley. LOW estimates were increased through 2012. Company should return to positive comp sales this year. Overweight rating and $27 price target.
Medtronic
(MDT) - Get Free Report
estimates lowered at Morgan Stanley. MDT estimates were reduced through 2012. Organic growth is slowing. Equal-weight rating.
Medtronic
(MDT) - Get Free Report
estimates boosted at UBS through 2011. Company is gaining market share in ICD's and seeing lower expenses. Buy rating and $53 price target.
Medco Health
(MHS)
estimates lowered at Morgan Stanley through 2011. Company is seeing multiple headwinds. Overweight rating and $75 price target.
NRG
(NRG) - Get Free Report
price target trimmed at BofA/Merrill by a dollar to $28. Valuation attractive, but obscured by nuclear expansion. Maintain Buy rating.
Office Depot
(ODP) - Get Free Report
price target raised at BofA/Merrill to $4.20 from $3.50 on improved liquidity and better than expected 4Q09 results. Estimates raised through 2012. Reiterate Underperform rating.
Office Depot
(ODP) - Get Free Report
estimates, target upped at Goldman. Shares of ODP now seen reaching $7. Estimates also raised, as the company is realizing higher gross margins. Neutral rating.
Procter & Gamble
(PG) - Get Free Report
numbers raised at Goldman. Shares of PG now seen reaching $70. Estimates also increased, given higher expected profit in liquid laundry detergent. Neutral rating.
Qualcomm
(QCOM) - Get Free Report
target, estimates slashed at Credit Suisse. QCOM price target sunk to $40 from $45 on chipset margin pressure. 2010 and 2011 EPS estimates lowered to $2.17 and $2.30, respectively. Maintain Neutral rating.
Sears Holdings
(SHLD)
estimates reduced at Goldman through 2011. Company is seeing lower comp sales. Sell rating and $61 price target.
Tenet Healthcare
(THC) - Get Free Report
numbers reduced at Goldman. Shares of THC now seen reaching $8. Estimates also cut, because of planned technology investments. Buy rating.
TIM Participacoes
(TSU) - Get Free Report
price target raised at Credit Suisse to $37 from $34 after strong 4Q09 results. Maintain Neutral rating.
Werstlake Chemical
(WLK) - Get Free Report
numbers lowered at Goldman through 2011. Company is seeing weak pricing in vinyls. Sell rating and new $22 price target.
Waste Management
(WM) - Get Free Report
price target raised at BofA/Merrill to $36 from $34 as stock and volumes are intertwined. 2010 EPS lowered to $2.16, 2011 raised to $2.65, 2012 introduced at $3.03. Maintain Buy rating.
Weight Watchers
(WTW) - Get Free Report
estimates cut at UBS through 2010. Company is facing unfavorable currency rates. Neutral rating and $28 price target.
This article was written by a staff member of TheStreet.com.
